Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England.
Tom BromilowHayden HolmesLaura CooteSam WoodsJoshua PinkPublished in: PharmacoEconomics - open (2023)
First-line vancomycin and second-line vancomycin was the most cost-effective treatment sequence at the NICE threshold for treating CDI in England. The main limitation of this study was that the initial cure and recurrence rates of each intervention were applied constantly across each line of treatment and each round of recurrence.